Geron Corp (GERN)

[jeffqdhsr]

Janssen just updated 10-17-18 a phase 3 ongoing clinical trial with Imetelstat

https://globaltrialfinder.janssen.com/trial/2015-002874-19

Now it’s a P3 trial , I think it’s possible J&J walking from the first collaboration agreement was possibly to wait for P3 results and since the agreement had a deadline date maybe they opted to end the agreement , while still holding onto the second agreement which IMO def keeps their foot in the door ! Was the stock drop a over reaction ? Possibly

Can anyone explain why J&J is still conducting a P3 of Imetelstat?